vs
美国国际集团（AII）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是美国国际集团的1.1倍（$75.5M vs $68.1M），美国国际集团自由现金流更多（$133.2M vs $14.4M）
美国国际集团（AIG）是一家美国跨国金融保险集团，业务遍及全球80多个国家和地区，截至2023年共有雇员25200人。集团核心业务分为三大板块：一般保险、人寿与退休服务，另设有一家独立的科技赋能子公司。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
AII vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$68.1M
自由现金流更多
AII
多$118.8M
$14.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $68.1M | $75.5M |
| 净利润 | $20.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 43.0% | 22.7% |
| 净利率 | 30.7% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.58 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AIIPBYI
| Q4 25 | $68.1M | $75.5M | ||
| Q3 25 | $62.0M | $54.5M | ||
| Q2 25 | $74.5M | $52.4M | ||
| Q1 25 | $71.9M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润AIIPBYI
| Q4 25 | $20.9M | — | ||
| Q3 25 | $13.2M | $8.8M | ||
| Q2 25 | $27.5M | $5.9M | ||
| Q1 25 | $38.1M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率AIIPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率AIIPBYI
| Q4 25 | 43.0% | 22.7% | ||
| Q3 25 | 30.3% | 17.6% | ||
| Q2 25 | 32.3% | 12.7% | ||
| Q1 25 | 59.7% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率AIIPBYI
| Q4 25 | 30.7% | — | ||
| Q3 25 | 21.2% | 16.2% | ||
| Q2 25 | 36.9% | 11.2% | ||
| Q1 25 | 53.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）AIIPBYI
| Q4 25 | $0.58 | $0.26 | ||
| Q3 25 | $0.67 | $0.17 | ||
| Q2 25 | $1.62 | $0.12 | ||
| Q1 25 | $2.78 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.0M | $97.5M |
| 总债务越低越好 | $618.0K | $22.7M |
| 股东权益账面价值 | $337.0M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资AIIPBYI
| Q4 25 | $222.0M | $97.5M | ||
| Q3 25 | $171.9M | $94.4M | ||
| Q2 25 | $259.6M | $96.0M | ||
| Q1 25 | $236.4M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务AIIPBYI
| Q4 25 | $618.0K | $22.7M | ||
| Q3 25 | $721.0K | $34.0M | ||
| Q2 25 | $824.0K | $45.3M | ||
| Q1 25 | $926.0K | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益AIIPBYI
| Q4 25 | $337.0M | $130.3M | ||
| Q3 25 | $315.9M | $115.3M | ||
| Q2 25 | $301.9M | $104.7M | ||
| Q1 25 | $186.1M | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产AIIPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.4B | $202.9M | ||
| Q2 25 | $1.6B | $194.9M | ||
| Q1 25 | $1.1B | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比AIIPBYI
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.43× | ||
| Q1 25 | 0.00× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $138.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $133.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 195.6% | 19.1% |
| 资本支出强度资本支出/营收 | 7.4% | 0.0% |
| 现金转化率经营现金流/净利润 | 6.62× | — |
| 过去12个月自由现金流最近4个季度 | $216.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流AIIPBYI
| Q4 25 | $138.2M | $14.4M | ||
| Q3 25 | $-7.5M | $9.7M | ||
| Q2 25 | $27.4M | $14.1M | ||
| Q1 25 | $68.1M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流AIIPBYI
| Q4 25 | $133.2M | $14.4M | ||
| Q3 25 | $-11.9M | $9.7M | ||
| Q2 25 | $26.9M | $14.1M | ||
| Q1 25 | $68.0M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率AIIPBYI
| Q4 25 | 195.6% | 19.1% | ||
| Q3 25 | -19.2% | 17.7% | ||
| Q2 25 | 36.1% | 26.8% | ||
| Q1 25 | 94.6% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度AIIPBYI
| Q4 25 | 7.4% | 0.0% | ||
| Q3 25 | 7.2% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率AIIPBYI
| Q4 25 | 6.62× | — | ||
| Q3 25 | -0.57× | 1.10× | ||
| Q2 25 | 1.00× | 2.41× | ||
| Q1 25 | 1.79× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
